Emergent BioSolutions

About:

Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats.

Website: http://emergentbiosolutions.com

Twitter/X: EmergentWeGo

Top Investors: U.S. Department of Defense, Biomedical Advanced Research and Development Authority (BARDA)

Description:

Emergent BioSolutions is a global life sciences company that is driven by a mission to protect and enhance life. It develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.

Total Funding Amount:

$287M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Gaithersburg, Maryland, United States

Founded Date:

1998-01-01

Contact Email:

schmittt(AT)ebsi.com

Founders:

Fuad El-Hibri

Number of Employees:

1001-5000

Last Funding Date:

2024-08-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai